Thus, we conclude that the treatments, by dampening the levels of pSTAT3(Y705) and pSTAT3(S727), inhibit the activities of STAT3 in the tumor, which correlate with the reduction in tumor growth. The gene discussed is STAT3; the disease is neoplasm.